Shares of Reliance Industries (RIL) hogged the limelight in Monday's session as they soared to a new lifetime high of Rs 2,477.70, up 4 per cent on the BSE on the back of positive news flow.
The company, after market hours, on Friday said its subsidiary had acquired a majority stake in genomic testing from Strand Life Sciences Pvt Ltd for Rs 393 crore. The acquisition by Reliance Strategic Business Ventures Ltd (RSBVL) is part of Reliance's digital health initiatives, the firm said in a recent stock exchange filing. READ MORE
In the past two sessions, the stock